{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:17:53Z","timestamp":1759515473274},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T00:00:00Z","timestamp":1216857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Post\u2010transplant lymphoproliferative disease (PTLD) can occur in different sites, such as lymph nodes, allograft, and central nervous system. We report a 6\u2010year\u2010old girl with end\u2010stage renal disease secondary to hypoplastic\u2013dysplastic kidneys, who received a kidney transplant. Thirty months post transplant, she developed PTLD in the tongue, an area of muscular tissue only. At that time her peripheral blood Epstein\u2013Barr viral (EBV) load was only 40 copies\/10<jats:sup>5<\/jats:sup> lymphocytes, though the tumor was EB early RNA (EBER) positive. Immunosuppression was reduced with initial improvement in her symptoms. One month later, she returned with abdominal complaints and a contained cecal abscess. The excised cecal tissue revealed CD20 and EBER\u2010positive lymphoid cells. At the same time, her peripheral blood EBV copy number rose to 400 copies\/10<jats:sup>5<\/jats:sup> lymphocytes. She was successfully treated for the progressive PTLD by complete cessation of immunosuppression and a modified reduced\u2010dose chemotherapy protocol plus rituximab. Partial immunosuppression was eventually re\u2010introduced with sirolimus and prednisone. She remains in remission 60 months post transplant, and 30 months post PTLD, with serum creatinine value maintained at 1.3\u2003mg\/dL. Unusual localization of PTLD to areas in non\u2010lymphoid tissue without regional lymphoid involvement may result in misleading low peripheral blood EBV viral loads.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2008.00328.x","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T10:51:17Z","timestamp":1216896677000},"page":"426-430","source":"Crossref","is-referenced-by-count":11,"title":["Low viral load post\u2010transplant lymphoproliferative disease localized within the tongue"],"prefix":"10.1111","volume":"10","author":[{"given":"D.D.","family":"Henry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.P.","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Braylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.R.","family":"Dharnidharka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,11,12]]},"reference":[{"key":"e_1_2_4_2_2","first-page":"835A","article-title":"Risk factors for PTLD","volume":"67","author":"Dharnidharka V","year":"1999","journal-title":"an analysis of the cases in the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)"},{"key":"e_1_2_4_3_2","first-page":"993","article-title":"Post\u2010transplant lymphoproliferative disorder in the United States","volume":"2","author":"Dharnidharka VR","year":"2002","journal-title":"young Caucasian males are at highest risk"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(03)00127-5"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.5.1346"},{"key":"e_1_2_4_6_2","first-page":"214","article-title":"Pretransplantation seronegative Epstein\u2013Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations","volume":"14","author":"Walker RC","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_4_7_2","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/jcm.35.6.1612-1615.1997","article-title":"Use of quantitative competitive PCR to measure Epstein\u2013Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders","volume":"35","author":"Rowe DT","year":"1997","journal-title":"J Clin Microbiol"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199509270-00005"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2004.00044.x"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/315828"},{"key":"e_1_2_4_11_2","first-page":"450","article-title":"Risk factors for post\u2010transplant lymphoproliferative disorder in pediatric patients","volume":"9","author":"Allen UD","year":"2005","journal-title":"a case\u2013control study"},{"key":"e_1_2_4_12_2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.38.2.712-715.2000","article-title":"Development of a real\u2010time quantitative assay for detection of Epstein\u2013Barr virus","volume":"38","author":"Niesters HG","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_4_13_2","first-page":"321","article-title":"Persistent increased Epstein\u2013Barr virus loads after solid organ transplantation","volume":"13","author":"Green M","year":"2007","journal-title":"truth and consequences?"},{"key":"e_1_2_4_14_2","first-page":"79","article-title":"Epstein\u2013Barr virus load monitoring","volume":"3","author":"Rowe DT","year":"2001","journal-title":"its role in the prevention and management of post-transplant lymphoproliferative disease"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00404.x"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02080.x"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200008270-00010"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.1999.00066.x"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2003.00080.x"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1017\/S002221510011374X"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/joms.2002.33870"},{"key":"e_1_2_4_22_2","first-page":"340","article-title":"Epstein\u2013Barr virus\u2010associated lymphoproliferative disease in oral cavity in a renal transplant recipient","volume":"11","author":"Johnson J","year":"2007","journal-title":"a case report"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2008.00328.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2008.00328.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T17:51:57Z","timestamp":1696873917000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2008.00328.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1399-3062.2008.00328.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2008.00328.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,12]]}}}